Table 2:
The number of participants with symptom presence/ number of participants with viral titers detectable or not detectable at each visit.
| Symptom | Baseline (n=12) |
Day 1-2 (n=9) | Day 4-5 (n=8) |
Day 7 (n=9) | Day 14 (n=8) | Day 21 (n=7) |
||
|---|---|---|---|---|---|---|---|---|
| 100% Virus detectable |
100% Virus detectable |
100% Virus Detectable |
Virus Detectable (n=5, 56%) |
Not Detectable (n=4, 44%) |
Virus Detectable (n=3, 33%) |
Not Detectable (n=6, 67%) |
100% Not detectable |
|
| Redness | 12/12 | 9/9 | 8/8 | 5/9 | 0/9 | 0/8 | 2/8 | 1/7 |
| Tearing | 11/12 | 8/9 | 8/8 | 4/9 | 3/9 | 1/8 | 0/8 | 0/7 |
| Discomfort | 12/12 | 9/9 | 8/8 | 4/9 | 3/9 | 1/8 | 3/8 | 2/7 |
| Swelling | 10/12 | 9/9 | 8/8 | 3/9 | 2/9 | 1/8 | 1/8 | 0/7 |
| Burning | 10/12 | 6/9 | 7/8 | 2/9 | 2/9 | 0/8 | 1/8 | 0/7 |
| Blurry Vision | 11/12 | 9/9 | 7/8 | 3/9 | 3/9 | 1/8 | 4/8 | 5/7 |
| Itching | 11/12 | 6/9 | 6/8 | 3/9 | 1/9 | 0/8 | 2/8 | 0/7 |
| Gritty | 12/12 | 8/9 | 6/8 | 4/9 | 1/9 | 1/8 | 2/8 | 1/7 |
| Matting | 11/12 | 9/9 | 8/8 | 4/9 | 3/9 | 1/8 | 0/8 | 0/7 |
| Sensitivity to Light | 11/12 | 7/9 | 7/8 | 2/9 | 3/9 | 0/8 | 3/8 | 2/7 |